THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 105 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is 56.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $3,852,000 | -10.1% | 169,910 | +1.5% | 0.00% | 0.0% |
Q4 2018 | $4,283,000 | -58.8% | 167,371 | -47.4% | 0.00% | 0.0% |
Q3 2018 | $10,386,000 | +267.9% | 317,932 | +155.4% | 0.00% | +50.0% |
Q2 2018 | $2,823,000 | -6.7% | 124,471 | -0.3% | 0.00% | 0.0% |
Q1 2018 | $3,027,000 | -13.8% | 124,812 | -0.8% | 0.00% | 0.0% |
Q4 2017 | $3,510,000 | -23.1% | 125,849 | -5.6% | 0.00% | -33.3% |
Q3 2017 | $4,563,000 | -25.7% | 133,266 | -13.6% | 0.00% | -25.0% |
Q2 2017 | $6,142,000 | +31.7% | 154,158 | +21.7% | 0.00% | +33.3% |
Q1 2017 | $4,665,000 | +8.0% | 126,686 | -6.5% | 0.00% | 0.0% |
Q4 2016 | $4,320,000 | -2.6% | 135,501 | +10.7% | 0.00% | 0.0% |
Q3 2016 | $4,436,000 | +56.5% | 122,401 | -2.0% | 0.00% | +50.0% |
Q2 2016 | $2,834,000 | +73.8% | 124,919 | +44.0% | 0.00% | +100.0% |
Q1 2016 | $1,631,000 | +22.3% | 86,779 | +6.6% | 0.00% | 0.0% |
Q4 2015 | $1,334,000 | +43.1% | 81,404 | -4.0% | 0.00% | 0.0% |
Q3 2015 | $932,000 | -14.2% | 84,816 | +1.6% | 0.00% | 0.0% |
Q2 2015 | $1,086,000 | -25.4% | 83,447 | -0.6% | 0.00% | 0.0% |
Q1 2015 | $1,456,000 | +16.3% | 83,931 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $1,252,000 | -49.6% | 83,931 | -22.1% | 0.00% | -50.0% |
Q3 2014 | $2,483,000 | -34.8% | 107,743 | -9.7% | 0.00% | -33.3% |
Q2 2014 | $3,806,000 | – | 119,378 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
King Wealth Management Group | 22,500 | $583,000 | 0.15% |
Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |